Evgen Pharma

Evgen Pharma was founded in 20007 and is based in Liverpool. It is a clinical stage drug development business focused on the treatment of cancer and neurological conditions. Its core technology is Sulforadex®, a patented, synthetic and stabilised version of a plant derived compound, sulforaphane. Sulforaphane is an established anti-cancer agent whose clinical and commercial development has, to date, been precluded by the instability of the molecule. The Group utilises its Sulforadex® technology to develop products that exploit the therapeutic properties of sulforaphane. The Group’s first development product, SFX-01, has completed Phase I trials and has been demonstrated to be safe and well tolerated.

Visit website


Get in Touch

Contact our head office here. If you'd like specific information on certain areas please consult our Investing and Advising pages.

01942 271 746